ea0013p86 | Clinical practice/governance and case reports | SFEBES2007
Cherukuri Vijay Nandini
, Mahto Rajni
, Ryan Sue
, Foley Malcolm
, Singh Baldev
, Buch Harit
Background: Radioiodine (RAI) has been used for the treatment of hyperthyroidism for over half a century without agreement about its dose or regime. Following our previously presented audit, over the last three years we have used a 400MBq fixed dose (FD) RAI regime for the management of patients with hyperthyroidism, replacing the calculated dose (CD) regime.Aim: To compare the cure rate following the use of a 400MBq fixed dose RAI regime with that achie...